Autologous bone marrow mixed with HLA-haploidentical allogeneic marrow transplantation for treatment of patients with malignant blood diseases

Bone Marrow Transplantation

Volumn 19, Issue 2, 1997, Pages 107-112

  Da, W M ^a   Liu, Y ^a   Zhong, J T ^a   Bai, H ^a   Ji, M J ^a   Wang, C B ^a   Lu, J Z ^a   Chen, J M ^a   Wang, Y L ^a   Wu, X X ^a   Xu, S F ^a   Zhang, Q ^a   Wei, Y M ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

Author keywords

Bone marrow transplantation; Malignant blood diseases; Mixed graft versus leukemia

Indexed keywords

ANTILEUKEMIC AGENT; HLA ANTIGEN; INTERLEUKIN 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2;

ACUTE LEUKEMIA; ADULT; ADVANCED CANCER; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW; BONE MARROW CULTURE; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHIMERA; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HYPERTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; ISOGRAFT; LIVER VENOOCCLUSIVE DISEASE; LYMPHOMA; MALE; PARENT; PRIORITY JOURNAL; RECURRENCE RISK; SEX CHROMOSOME; SIBLING;

EID: 0031032094     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700627     Document Type: Article

References (19)

1. Horowitz MM. New IBMTR/ABMTR slides summarized current use and outcome of allogeneic and autologous transplantation. IBMTR News 1995, 2: 2-9.
2. Thomas ED. Hematopoietic stem cell transplantation. Sci Med 1995; Sept/Oct: 38-47.
3. Christiansen NP. Allogeneic bone marrow transplantation for the treatment of adult acute leukemias. Hematol Oncol Clin North Am 1993; 7: 177-200.
4. Ball ED, Rybka WB. Autologous bone marrow transplantation for adult acute leukemia. Hematol Oncol Clin North Am 1993; 7: 201-231.
5. Da WM, Zhong JT, Liu Y et al. Prolonged disease-free survival of ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma. Chin Med J 1993; 106: 277-281.
6. Bai H, Da WM, Dong GP et al. In vitro separation of bone marrow nuclear cells with methylcellulose and its application to autologous bone marrow transplantation in patients with leukemia. Chin J Intern Med 1994; 33: 103-105.
7. Da WM, Liu Y, Wei SN. Studies on sensitivity of human GM-CFU and L-CFU to hyperthermic killing in vitro. Leuk Res 1989; 13: 217-220.
8. Bernaudin F, Beaujean F, Lemerle et al. Induction of antileukemic cytotoxicity by culture with R-IL-2. Bone Marrow Transplant 1988; 3 (Suppl. 1): 116-117.
9. Da WM, Zhong JT, Liu Y, Huang YS. Long-term following of adult patients with malignant lymphoma treated by autologous bone marrow transplantation. J Chin Clin Hematol 1992; 5: 111-114.
10. Sykes M, Abraham VS, Harty WM, Pearson DA. IL2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. J Immunol 1993; 150: 197-205.
11. Sykes M, Harty MW, Szot GL et al. Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4-and CDS-mediated graft-versus-leukemia effects. Blood 1994; 83: 2560-2569.
12. Sykes M, Abraham VS. 1L-2 induced separation of GVHD-promoting and GVL effects of allogeneic cells does not depend on host-versus-graft alloreactivity. Bone Marrow Transplant 1995; 15 (Suppl. 1): 72-77.
13. Mayumi H, Goo RA. Long-lasting allogeneic tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor) histocompatibility antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med 1989; 169: 213-238.
14. Miller RG. The veto phenomenon and T-cell regulation. Immunol Today 1986; 7: 112-114.
15. Sykes M, Bukhari Z, Sachs DH. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 465-174.
16. Da WM, Bai H., Ji MJ et al. Experimental study on graft-versus-leukemic effect using syngeneic mixed with H-2 haploidentical marrow transplantation. J Exp Hematol 1996; 4: 101-105.
17. Beaujaen F, Bernaudin F, Kuentz M et al. Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia. Bone Marrow Transplant 1994; 15: 691-696.
18. Schiller G, Gale P. Is there an effective therapy for chronic graft-versus-host disease? Bone Marrow Transplant 1993; 11: 189-192.
19. Charak BS, Brynes RK, Grashen S et a/. Bone marrow transplantation with IL2 activated bone marrow followed by IL2 therapy for acute myeloid leukemia in mice. Blood 1990; 76: 2187-2190.